• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MRI 监测小中型前庭神经鞘瘤:生长预测因素。

MRI monitoring of small and medium-sized vestibular schwannomas: predictors of growth.

机构信息

Department of Otolaryngology and Otoneurosurgery, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Claude Bernard University Lyon 1, Lyon, France.

Department of Biostatistics, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Claude Bernard University Lyon 1, Lyon, France.

出版信息

Acta Otolaryngol. 2020 May;140(5):361-365. doi: 10.1080/00016489.2020.1717608. Epub 2020 Feb 12.

DOI:10.1080/00016489.2020.1717608
PMID:32049566
Abstract

Vestibular schwannomas are among the most common intracranial tumours. Their growth is difficult to predict. To study the evolution of small and medium-sized vestibular schwannomas (VSs) and identify factors predictive of growth. This was a retrospective longitudinal study at a tertiary referral centre from January 2011 to January 2018. The inclusion criteria were radiological diagnosis of sporadic unilateral VS of stage I or II. Radiological and clinical data were analysed descriptively and by multivariate logistic regression to identify factors predictive of growth. A total of 1105 cases were discussed in multidisciplinary meetings and 336 patients were included with a mean age of 57.8 years and a mean follow-up time of 24 months. Around two thirds of these patients (62.8%) had non-progressive tumours. Factors identified as predictive of VS growth were the size at diagnosis (OR = 2.622, 95% CI, 1.50-4.66;  = .001) and internal auditory canal filling (OR = 7.672; 95% CI, 4.52-13.43;  < .001). Monitoring is the primary treatment modality for small or medium-sized VSs. As reported here for the first time, internal auditory canal filling is significantly associated with VS growth.

摘要

前庭神经鞘瘤是最常见的颅内肿瘤之一。其生长难以预测。本研究旨在探讨小、中型前庭神经鞘瘤(VS)的演变,并确定生长的预测因素。这是一项 2011 年 1 月至 2018 年 1 月在三级转诊中心进行的回顾性纵向研究。纳入标准为影像学诊断为单侧Ⅰ期或Ⅱ期散发性 VS。对影像学和临床数据进行描述性和多变量逻辑回归分析,以确定生长的预测因素。在多学科会议上讨论了 1105 例病例,其中 336 例患者符合条件,平均年龄为 57.8 岁,平均随访时间为 24 个月。这些患者中有近三分之二(62.8%)的肿瘤无进展。被确定为 VS 生长预测因素的因素包括诊断时的大小(OR=2.622,95%CI,1.50-4.66;  = .001)和内听道充盈(OR=7.672;95%CI,4.52-13.43;  < .001)。监测是小或中型 VS 的主要治疗方法。正如这里首次报道的,内听道充盈与 VS 生长显著相关。

相似文献

1
MRI monitoring of small and medium-sized vestibular schwannomas: predictors of growth.MRI 监测小中型前庭神经鞘瘤:生长预测因素。
Acta Otolaryngol. 2020 May;140(5):361-365. doi: 10.1080/00016489.2020.1717608. Epub 2020 Feb 12.
2
Magnetic resonance imaging characteristics and the prediction of outcome of vestibular schwannomas following Gamma Knife radiosurgery.伽玛刀放射外科治疗前庭神经鞘瘤后的磁共振成像特征及其对预后的预测。
J Neurosurg. 2017 Dec;127(6):1384-1391. doi: 10.3171/2016.9.JNS161510. Epub 2017 Feb 10.
3
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Imaging in the Diagnosis and Management of Patients With Vestibular Schwannomas.神经外科医师学会系统评价及基于证据的指南:关于影像学在前庭神经鞘瘤患者诊断和治疗中的作用。
Neurosurgery. 2018 Feb 1;82(2):E32-E34. doi: 10.1093/neuros/nyx510.
4
Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas.伽玛刀放射外科治疗神经纤维瘤病 2 型伴生长性前庭神经鞘瘤患者:与散发性前庭神经鞘瘤的匹配队列研究。
J Neurosurg. 2018 Jan;128(1):49-59. doi: 10.3171/2016.9.JNS161463. Epub 2017 Jan 27.
5
The natural history of untreated vestibular schwannomas. Is there a role for conservative management?未治疗的前庭神经鞘瘤的自然病史。保守治疗是否有作用?
Rev Laryngol Otol Rhinol (Bord). 2000;121(1):21-6.
6
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Hearing Preservation Outcomes in Patients With Sporadic Vestibular Schwannomas.美国神经外科学会关于散发前庭神经鞘瘤患者听力保护结果的系统评价和循证指南
Neurosurgery. 2018 Feb 1;82(2):E35-E39. doi: 10.1093/neuros/nyx511.
7
Association of Metformin With the Growth of Vestibular Schwannomas.二甲双胍与前庭神经鞘瘤生长的关联
Otolaryngol Head Neck Surg. 2021 Jan;164(1):182-187. doi: 10.1177/0194599820937970. Epub 2020 Jul 7.
8
Conservative management of vestibular schwannomas - second review of a prospective longitudinal study.前庭神经鞘瘤的保守治疗——一项前瞻性纵向研究的二次综述
Clin Otolaryngol Allied Sci. 2004 Oct;29(5):505-14. doi: 10.1111/j.1365-2273.2004.00852.x.
9
Vestibular schwannomas - when should conservative management be reconsidered?前庭神经鞘瘤——何时应重新考虑保守治疗?
Br J Neurosurg. 2010 Apr;24(2):185-90. doi: 10.3109/02688690903272634.
10
Gamma Knife radiosurgery for large vestibular schwannomas greater than 3 cm in diameter.伽玛刀放射外科治疗直径大于 3 厘米的大型前庭神经鞘瘤。
J Neurosurg. 2018 May;128(5):1380-1387. doi: 10.3171/2016.12.JNS161530. Epub 2017 Jul 14.

引用本文的文献

1
Untreated Vestibular Schwannoma: Analysis of the Determinants of Growth.未治疗的前庭神经鞘瘤:生长决定因素分析
Cancers (Basel). 2024 Nov 4;16(21):3718. doi: 10.3390/cancers16213718.
2
Surgery versus radiosurgery for vestibular schwannoma: Shared decision making in a multidisciplinary clinic.前庭神经鞘瘤的手术与放射外科治疗:多学科诊所中的共同决策
Neurooncol Adv. 2023 Jul 19;5(1):vdad089. doi: 10.1093/noajnl/vdad089. eCollection 2023 Jan-Dec.
3
Factors Influencing Personalized Management of Vestibular Schwannoma: A Systematic Review.
影响前庭神经鞘瘤个体化管理的因素:一项系统评价
J Pers Med. 2022 Sep 30;12(10):1616. doi: 10.3390/jpm12101616.
4
The study of predictive factors for the evolution of vestibular schwannomas.研究听神经鞘瘤演变的预测因素。
Eur Arch Otorhinolaryngol. 2023 Apr;280(4):1661-1670. doi: 10.1007/s00405-022-07651-w. Epub 2022 Sep 16.